High Peripheral T Cell Diversity is Associated with Lower Risk of Toxicity and Superior Response to Dual Immune Checkpoint Inhibitor Therapy in Patients with Metastatic NSCLC
JOURNAL FOR IMMUNOTHERAPY OF CANCER(2024)
关键词
Lung Cancer,T cell Receptor - TCR,Immune Checkpoint Inhibitor,Immune related adverse event - irAE
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要